Creatinine Clearance Calculator

Cockcroft–Gault, CKD-EPI 2021 & KDIGO staging.

All calculators
Patient details
Sex
Age
18406080100
Serum creatinine
Most recent stable value
Body units
Weight
Height
Dosing weight

Cockcroft–Gault was derived with actual body weight. In underweight patients many clinicians use actual; in obesity, ideal or adjusted body weight reduces overestimation.

Creatinine clearance
Cockcroft–Gault CrClG2 · Mildly decreased
87.3mL/min

Normalised 76.6 mL/min/1.73m² · dosing weight 80.0 kg

77G5G4G3bG3aG2G11530456090
CKD-EPI 2021 eGFR84.4 mL/min/1.73m²
Body surface area1.97 m²
Serum creatinine90 µmol/L
Estimates compared
Cockcroft–Gault · actual (80.0 kg)87.3mL/min
Cockcroft–Gault · ideal (70.5 kg)76.9mL/min
Cockcroft–Gault · adjusted (74.3 kg)81.1mL/min
Cockcroft–Gault · normalised76.6/1.73m²
CKD-EPI 2021 (eGFR)84.4/1.73m²
Equations & working
Cockcroft–Gault (1976)
CrCl = (140 − age) × weightkg × 1.00 ÷ (72 × SCrmg/dL)
= (140 − 60) × 80.0 × 1.00 ÷ (72 × 1.02) = 87.3 mL/min
Serum creatinine conversion
mg/dL = µmol/L ÷ 88.42
90 µmol/L ÷ 88.42 = 1.02 mg/dL
Ideal body weight — Devine (1974)
IBW = 50 + 2.3 × (heightin − 60)
= 50 + 2.3 × (68.9 − 60) = 70.5 kg
Adjusted body weight
AdjBW = IBW + 0.4 × (actual − IBW)
= 70.5 + 0.4 × (80.0 − 70.5) = 74.3 kg
Body surface area — Mosteller (1987)
BSA = √(heightcm × weightkg ÷ 3600)
= √(175 × 80.0 ÷ 3600) = 1.97 m²
CKD-EPI 2021 creatinine (race-free)
142 × min(SCr/κ,1)α × max(SCr/κ,1)−1.200 × 0.9938age
κ = 0.9, α = −0.302 → 84.4 mL/min/1.73m²
Measured CrCl — 24-hour urine (reference standard)
Urine creatinine
Urine volume
Collection time
Measured creatinine clearance102.3 mL/min89.8 mL/min/1.73m² normalised
CrCl = (Ucr ÷ Pcr) × (volume ÷ time) = (98 ) × (1,500 mL ÷ 1,440 min)

For education and planning only — not a substitute for clinical judgement or laboratory reporting. Cockcroft–Gault and CKD-EPI assume stable renal function and are unreliable in acute kidney injury, pregnancy, extremes of body size, or rapidly changing creatinine. KDIGO GFR categories (G1–G5) are defined on BSA-normalised GFR and, for G1–G2, require additional markers of kidney damage to indicate CKD. Results depend on a standardised (IDMS-traceable) creatinine assay. Always confirm drug dosing against the approved product information and local guidelines, and consult a qualified clinician.